Glaucoma Portugal Screening Trial (Glaucoma PoST)
Glaucoma
About this trial
This is an interventional screening trial for Glaucoma focused on measuring Screening
Eligibility Criteria
Inclusion Criteria: subjects age between 55 to 65 years old registered in the primary care area of either ACES Lisbon Norte (Lisbon arm) or in the area of ACES Alto Minho (Minho arm) willingness to sign an informed consent for the screening process Exclusion Criteria: - none Poor quality in screening image will be included in the intention to treat analysis, but excluded from the diagnostic comparator outcome. Patients with a known glaucoma diagnosis will not be excluded from the screening
Sites / Locations
- Equipa Regional dos Programas de Rastreio da Região de Saúde de Lisboa e Vale do Tejo
- Centro Hospitalar Lisbon Norte
- Unidade Local Saude Alto Minho
Arms of the Study
Arm 1
Arm 2
Experimental
Active Comparator
AI-enhanced Retinography-based screening
OCT-based screening
Screening in Lisbon arm will be done by an Artificial Intelligence (AI) software reading an optic disc entered retinography. Outcome of this analysis is referral vs non-referral based on a pre-established threshold. IOP 24mmHg or higher will be also be referred, regardless of optics disc analysis
Screening in the Minho arm will be done based on optic coherence Tomography (OCT) retinal nerve fibre layer thickness (RNFL). Existence of a single sector outside normal limits (>95%) will be considered referrable. IOP 24mmHg or higher will be also be referred, regardless of optics disc analysis